Literature DB >> 30279795

Replacement myocardial fibrosis at the site of late gadolinium enhancement on magnetic resonance imaging in a patient with diffuse cutaneous systemic sclerosis: An autopsy report.

Atsushi Noguchi1, Ichizo Tsujino2, Noriko Oyama-Manabe3, Mishie Tanino4.   

Abstract

Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is a well-known finding indicative of cardiac involvement in systemic sclerosis (SSc heart). However, few studies have reported the precise histopathology at the site of LGE. We present an autopsy report of a 51-year-old man diagnosed with diffuse cutaneous SSc according to a systematic diagnostic workup, including skin biopsy. CMR indicated left ventricular (LV) dilatation and broadly distributed subendocardial LGE in the LV walls. The patient was treated with methylprednisolone pulse therapy because of multiple episodes of ventricular tachycardia, whereas he subsequently died of left heart failure. An autopsy study revealed broad subendocardial replacement fibrosis, concomitant with the distribution of LGE on CMR, without inflammatory or edematous changes. Notably, myocardial fibrosis was evident around the intramural coronary arteries, although the arteries themselves were intact. These findings demonstrated that broad subendocardial LGE on CMR reflected replacement myocardial fibrosis in a patient with diffuse cutaneous SSc. These clinicopathological observations suggested that spasms in the intramyocardial arteries or the cardiac Raynaud's phenomenon may have provoked broad subendocardial fibrosis of the LV walls. <Learning objective: The present autopsy report pathologically validated the presence of broad myocardial fibrosis in the area of subendocardial late gadolinium enhancement (LGE) on cardiac magnetic resonance in a patient with systemic sclerosis (SSc). Lack of inflammatory changes along with intact coronary arteries suggested the involvement of intramural coronary spasm in the development of cardiac involvement in SSc. Such an LGE pattern may suggest end-stage cardiac involvement and portend a poor prognosis.>.

Entities:  

Keywords:  Cardiac Raynaud’s phenomenon; Late gadolinium enhancement; Myocardial fibrosis; Pathological evaluation; Systemic sclerosis

Year:  2017        PMID: 30279795      PMCID: PMC6149262          DOI: 10.1016/j.jccase.2017.04.005

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  11 in total

Review 1.  Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.

Authors:  Y Allanore; C Meune
Journal:  Clin Exp Rheumatol       Date:  2010-11-03       Impact factor: 4.473

2.  Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis.

Authors:  Sophie I Mavrogeni; Konstantinos Bratis; Georgia Karabela; George Spiliotis; Kees van Wijk; David Hautemann; Johan H C Reiber; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; Genovefa Kolovou; Efthymios Stavropoulos
Journal:  Inflamm Allergy Drug Targets       Date:  2015

3.  Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.

Authors:  B H Bulkley; R L Ridolfi; W R Salyer; G M Hutchins
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

4.  Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.

Authors:  E L Alexander; G S Firestein; J L Weiss; R R Heuser; G Leitl; H N Wagner; J A Brinker; A A Ciuffo; L C Becker
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

5.  Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.

Authors:  George E Tzelepis; Nikolaos L Kelekis; Sotiris C Plastiras; Panayiotis Mitseas; Nikolaos Economopoulos; Christos Kampolis; Elias J Gialafos; Ioannis Moyssakis; Haralampos M Moutsopoulos
Journal:  Arthritis Rheum       Date:  2007-11

6.  Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.

Authors:  Heiko Mahrholdt; Christine Goedecke; Anja Wagner; Gabriel Meinhardt; Anasthasios Athanasiadis; Holger Vogelsberg; Peter Fritz; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

7.  Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study.

Authors:  Reiko Mizuno; Shinichi Fujimoto; Yoshihiko Saito; Shinobu Nakamura
Journal:  Eur J Heart Fail       Date:  2010-01-12       Impact factor: 15.534

8.  Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.

Authors:  Maurizio Pieroni; Maria De Santis; Gaetano Zizzo; Silvia Bosello; Costantino Smaldone; Mara Campioni; Giacomo De Luca; Antonella Laria; Agostino Meduri; Fulvio Bellocci; Lorenzo Bonomo; Filippo Crea; Gianfranco Ferraccioli
Journal:  Semin Arthritis Rheum       Date:  2013-08-06       Impact factor: 5.532

9.  Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis.

Authors:  Patrick Krumm; Karin A L Mueller; Karin Klingel; Ulrich Kramer; Marius S Horger; Tanja Zitzelsberger; Reinhard Kandolf; Meinrad Gawaz; Konstantin Nikolaou; Bernhard D Klumpp; Joerg C Henes
Journal:  J Cardiovasc Magn Reson       Date:  2016-10-21       Impact factor: 5.364

10.  Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.

Authors:  Makoto Sano; Hiroshi Satoh; Kenichiro Suwa; Mamoru Nobuhara; Takeji Saitoh; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Kumiko Shimoyama; Daisuke Suzuki; Noriyoshi Ogawa; Yasuo Takehara; Harumi Sakahara; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2014-07-05       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.